Loading...
Loading...
MEUSW| Name | Value |
|---|---|
| Revenues | 44.7M |
| Cost of Revenue | 24.8M |
| Gross Profit | 19.9M |
| Operating Expense | 100.8M |
| Operating I/L | -281.2M |
| Other Income/Expense | 3.3M |
| Interest Income | 3.2M |
| Pretax | -278.0M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -278.0M |
23andMe, Inc. is a consumer genetics and research company that provides direct-to-consumer genetic testing and personalized information about genetic health risks, ancestry, and traits. The company also operates a crowdsourced platform to help people access and understand their genetic information. Additionally, 23andMe leverages its genetic database to facilitate the rapid discovery of new drug development targets, offering potential opportunities for collaboration with pharmaceutical companies and researchers.
